Does LENVATINIB Cause Hepatic encephalopathy? 502 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 502 reports of Hepatic encephalopathy have been filed in association with LENVATINIB (Lenvima). This represents 1.5% of all adverse event reports for LENVATINIB.
502
Reports of Hepatic encephalopathy with LENVATINIB
1.5%
of all LENVATINIB reports
76
Deaths
432
Hospitalizations
How Dangerous Is Hepatic encephalopathy From LENVATINIB?
Of the 502 reports, 76 (15.1%) resulted in death, 432 (86.1%) required hospitalization, and 17 (3.4%) were considered life-threatening.
Is Hepatic encephalopathy Listed in the Official Label?
Yes, Hepatic encephalopathy is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Hepatic encephalopathy?
ACETAMINOPHEN (562)
RIBAVIRIN (512)
RIFAXIMIN (462)
SOFOSBUVIR (360)
BEVACIZUMAB (210)
LEDIPASVIR\SOFOSBUVIR (180)
ATEZOLIZUMAB (178)
SORAFENIB (169)
DACLATASVIR (165)
FUROSEMIDE (130)
Which LENVATINIB Alternatives Have Lower Hepatic encephalopathy Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE